Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein ...

Recently, the development of nanozymes with high catalytic performance is gaining more and more attention due to the ever-growing demands for their practical applications. The elaborate design of its ...

Emergent stock is down >40% since my last update. I had given the EBS stock a "Buy" rating but noted that 2025 may be a ...

Parataxis is launching a Bitcoin treasury platform for South Korean institutional investors, which saw Bridge Bio’s stock ...